Marta Arimont

发表

Modulators of CXCR4 and CXCR7/ACKR3 Function

I. D. de Esch, R. Leurs, C. de Graaf, 2019, Molecular Pharmacology.

Structural Analysis of Chemokine Receptor–Ligand Interactions

I. D. de Esch, R. Leurs, C. de Graaf, 2017, Journal of medicinal chemistry.

CXCR4‐targeting nanobodies differentially inhibit CXCR4 function and HIV entry

C. de Graaf, T. Handel, M. Smit, 2018, Biochemical pharmacology.

Identification of Key Structural Motifs Involved in 7 Transmembrane Signaling of Adhesion GPCRs

R. Leurs, C. de Graaf, H. Vischer, 2019, ACS Pharmacology & Translational Science.

Chemokine Receptor Crystal Structures: What Can Be Learned from Them?

R. Leurs, C. Hoffmann, C. de Graaf, 2019, Molecular Pharmacology.

Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists

M. Lohse, C. Hoffmann, P. Annibale, 2020, Proceedings of the National Academy of Sciences.

Nanobody‐Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4‐mediated HIV‐entry and induce antibody effector functions

M. Smit, T. Van Loy, D. Schols, 2018, Biochemical pharmacology.

Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

M. Smit, H. de Haard, A. Zarca, 2019, Molecular Pharmacology.

Special Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function –Minireview Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

M. Smit, H. Haard, A. Zarca, 2019 .

Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

I. D. de Esch, R. Leurs, C. Hoffmann, 2019, European journal of medicinal chemistry.